The structure was visualized with PyMOL. Collectively, the experimental results and modeling suggest that the RBD has a well-defined structure of a three-helix fold, which forms a spatial cluster of important amino acids in the interface of helix 1 and 3. 3.4. process of B19V and further explain the efficient neutralization of B19V by antibodies against the VP1u region. 2. Materials and Methods 2.1. Cells and Viruses UT7/Epo cells were kindly provided by Eiji Morita (Tohoku University or college School of Medicine, Sendai, Japan) and produced in RPMI 1640, 5% fetal calf serum (FCS), 2 U/mL recombinant human being erythropoietin (rhEPO), supplemented with l-glutamine and penicillin/streptomycin. Human being plasma from a parvovirus B19 infected person (5 109 virions/L, genotype 1) was from our donation center (CSL Behring AG, Charlotte, NC, USA). 2.2. Mutation and Manifestation of Recombinant VP1u The VP1u sequence originally derived from the infectious clone pB19-M20 (Susan Wong, National Institutes of Health, Bethesda, MD, USA) and was cloned into the pT7-FLAG-MAT-Tag-2 manifestation vector (Sigma, St. Louis, MO, USA) as previously explained [16]. Mutations and truncations were launched by QuikChange PCR (Agilent Systems, Santa Clara, CA, USA) and confirmed by sequencing. The manifestation of the recombinant VP1u protein was carried out in BL21(DE3) and lysogeny broth press comprising ampicillin. The bacteria culture was produced until an OD600 of ~0.5 to induce then protein expression with 1 mM isopropyl–d-thiogalactopyranoside (IPTG) for 4 h at 37 C. The pelleted cells were resuspended in phosphate buffered saline (PBS, pH 8) with 5 mM imidazole, and sonicated for 15 10 NSC 33994 s. Cell debris was eliminated by centrifugation at 4 C, 12000 B19V. Viral internalization was allowed for 40 min at 37 C. After removal of non-internalized virions by washes and trypsinization, the internalized viral DNA was extracted (DNeasy Blood and Tissue Kit; Qiagen, Hilden, Germany) and quantified by iTaq SybrGreen qPCR (BioRad, Hercules, CA, USA; ahead primer: 5-GGGCAGCCATTTTAAGTGTTT-3; opposite primer: 5-CCAGGAAAAAGCAGCCCAG-3). 2.5. VP1u-Fluorescein Conjugation Recombinant ?C126 VP1u (1 mg/mL) was labeled having a 20-fold molecular excess maleimide-fluorescein (Thermo Scientific, Waltham, MA, USA) in PBS (pH 7) and 5 mM tris(2-carboxyethyl)phosphine (TCEP). The coupling reaction was performed for 2 h at space temperature and over night at 4 C. The VP1u-fluorescein conjugate was purified with Ni-NTA and the crosslinking was verified by SDS PAGE. 2.6. VP1u-DNA Conjugation with Sense and Antisense Oligonucleotides The complementary oligonucleotides for VP1u-conjugation were designed with a minimal length to allow specific qPCR (39 nt), and having a sequence that does not allow self-hybridization. For Click Chemistry conjugation with the VP1u, the sense and antisense oligonucleotides (39 nt) were NSC 33994 altered with an azide residue either in the 5 or 3 of the oligonucleotide (azide-5-GACTGGGACGCTGGACTGACCGGAGAGGTGGTGGAGGAG-3 (sense); 5-CTCCTCC ACCACCTCTCCGGTCAGTCCAGCGTCCCAGTC-3-azide (antisense)). Oligonucleotide synthesis and NSC 33994 azide-modification were provided by Microsynth. The azide-modified oligonucleotides (0.2 mM) were coupled to 10 mM alkyne-PEG4-maleimide using Cu(I) catalysis (0.5 mM CuSO4, 0.5 mM tris(benzyltriazolylmethyl)amine (TBTA), 0.5 mM ascorbate)). The reaction was performed in 50% DMSO, 150 mM phosphate buffer (pH 6.75) for 3 h at space temperature. The maleimide-activated oligonucleotides were pelleted by acetone precipitation (85% acetone, ?20 C) and washed LSP1 antibody with real acetone. The purified, washed and dried pellet of maleimide-activated oligonucleotides was resuspended in 150 mM phosphate buffer (pH 6.75, 0.2 mM final concentration of NSC 33994 oligonucleotides) and incubated with reduced ?C126 (0.01 mM) to accomplish VP1u-DNA conjugation (over night at 4 C, 5 mM TCEP). VP1u-DNA conjugates were further purified by Ni-NTA agarose and analyzed for coupling effectiveness by SDS PAGE and Western blot. Binding and internalization experiments with VP1u-DNA conjugates were performed as specified above. Since DNA extraction with silica columns does not allow isolation of short oligonucleotides, the internalized VP1u-DNA (39 nt) was prepared for qPCR by cell lysis (Triton X-100) and Chelex? treatment. Quantitative PCR of the VP1u-DNA (39 nt) was performed with the primers.